Acquired Hemophagocytic Syndrome in a Patient With Synovial Sarcoma: a Case Report
Author(s) -
Chiara Ciccarese,
Roberto Ferrara,
Emanuela Fantinel,
Camilla Zecchetto,
Francesca Simionato,
Elisabetta Grego,
Silvia Ortolani,
Mario Caccese,
Davide Bimbatti,
Sara Cingarlini,
Matteo Brunelli,
A Andreini,
Giampaolo Tortora,
Francesco Massari
Publication year - 2015
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fso.15.27
Subject(s) - hemophagocytosis , hepatosplenomegaly , hemophagocytic lymphohistiocytosis , medicine , hypertriglyceridemia , pathology , complication , immunology , bone marrow , pancytopenia , disease , triglyceride , cholesterol
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by severe hyperinflammation due to an overwhelming ineffective immune response to different triggers. Most important symptoms are fever, hepatosplenomegaly and cytopenias. Biochemical signs include elevated ferritin, hypertriglyceridemia and low fibrinogen. Hemophagocytosis in the bone marrow is a hallmark of this syndrome. Based on the pathogenetic mechanism, it can be classified into primary (inherited) or secondary (acquired) HLH. We report, to our knowledge, the first case of acquired hemophagocytic syndrome that arose in a 20-year-old man affected by synovial sarcoma as a complication during chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom